Skip to main content

Table 5 Analysis of the multivariate Cox regression model for late recurrent E

From: Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer

 

B

SE

Wald

HR (95% CI)

P

Treatment course

0.561

0.232

5.837

1.752(1.112–2.762)

0.016

CA125 level

0.562

0.245

5.268

1.755(1.086–2.837)

0.022

Recurrent lesions

0.181

0.271

0.446

1.198(0.705–2.037)

0.504

Adverse reactions

0.362

0.288

1.579

1.436(0.817–2.526)

0.209

Surgery

0.055

0.260

0.045

1.056(0.635–1.758)

0.833

Ascites

−0.276

0.277

0.993

0.758(0.440–1.306)

0.319

Basic illness

0.140

0.237

0.352

1.151(0.724–1.830)

0.553